&sq=&lang=&file=File:Shire_logo.svg){kind=logo} | |
| Company type | Subsidiary[1] |
|---|---|
| Nasdaq: SHPG | |
| ISIN | JE00B2QKY057 |
| Industry | Pharmaceuticals |
| Predecessor | Shire Pharmaceuticals Group Plc |
| Founded | 1986 |
| Defunct | 2019 |
| Fate | Acquired by Takeda |
| Headquarters | Massachusetts, United States[2][3] |
Key people | Flemming Ornskov (CEO) Thomas Dittrich (CFO) |
| Revenue | $15,160.6 million (2017)[4] |
| $2,455.2 million (2017)[4] | |
| $4,271.5 million (2017)[4] | |
Number of employees | 23,044 (2018)[5] |
| Parent | Takeda Pharmaceutical Company (2019) |
| Website | www.shire.com |
Shire plc was a UK-founded Jersey-registered specialty biopharmaceutical company. Originating in the United Kingdom with an operational base in the United States, its brands and products included Vyvanse, Lialda, and Adderall XR. Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.
Shire was a global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. The company's products were available in more than 100 countries across core therapeutic areas including Hematology, Immunology, Neuroscience, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; a growing franchise in Oncology; and an emerging, innovative pipeline in Ophthalmics.
The original corporate headquarters was located in Basingstoke, Hampshire, England. Main offices are located in Dublin, Ireland, the United States in Cambridge, Massachusetts, and Chicago, Illinois, and in Zug, Switzerland. In addition, Shire owns manufacturing sites in Lexington, Massachusetts, and Social Circle, Georgia. Shire's headquarters in Lexington, Massachusetts, will be integrated with Takeda's new U.S. headquarters, which is being relocated from Deerfield, Illinois, to the Boston area.
- ^ "Takeda completes buyout of Shire to become top 10 global pharmaceutical firm". 8 January 2019. Archived from the original on 26 February 2021. Retrieved 22 February 2021.
- ^ DeAngelis, Allison (7 January 2019). "Takeda closes $62B purchase of Shire, creating largest Mass. biotech employer". Boston Business Journal. Archived from the original on 28 February 2022. Retrieved 24 February 2021.
- ^ "Contact us | Takeda Pharmaceuticals U.S.A., Inc". Archived from the original on 25 February 2021. Retrieved 24 February 2021.
- ^ a b c "Preliminary Results 2017" (PDF). Shire. Archived (PDF) from the original on 17 March 2018. Retrieved 17 March 2018.
- ^ "Shire Company Profile". craft.co. Archived from the original on 8 October 2019. Retrieved 8 October 2019.